Tute Genomics, a Utah-based company founded in 2012, is at the forefront of genomic innovation. The company's mission is to revolutionize healthcare by leveraging cloud-based solutions for precision genome-guided medicine. With a focus on biotechnology and healthcare, Tute Genomics is harnessing the power of genomics to personalize treatment, unlock the genome, and drive groundbreaking discoveries. Their recent Series A investment of $3.90M on 16 June 2015 attracted notable investors including Healthbox, Eurovestech, Tencent, and Intermountain Healthcare. Tute Genomics stands as a promising player in the genomics industry, poised to shape the future of medicine through innovation and strategic partnerships.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $3.90M | 4 |
|
16 Jun 2015 |
| Series A | $2.30M | 3 |
|
01 Dec 2014 |
| Seed Round | $1.50M | 3 |
|
01 Jan 2014 |
| Venture Round | Unknown | - | 01 Jan 2013 |
No recent news or press coverage available for Tute Genomics.
We care about your data, and we'd love to use cookies make your experience better.
